Advanced 3D cell models recreate the complexity of human tissues, enabling researchers to examine tumor progression, probe neurological disorders, and assess therapeutic candidates. By capturing the ...
Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...
U-shaped microcavities made of PEG hydrogel ensure consistent, uniform organoid formation for reliable 3D culture results. InSphero Logo InSphero acquires DOPPL SA and Sun Bio’s Gri3D® platform, ...
Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...
3D bio-printed liver model and high-content imaging for evaluating the toxicity effects of compounds
The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...
In associate professor Mauro Tambasco's lab, researchers at all levels work together to develop innovative approaches to fighting cancer.
New confocal fluorescence imaging minimizes photobleaching and phototoxicity effects, capturing clear images of live 3D culture Industry-leading throughput enables real-time analysis of up to six ...
Cancer research has long relied on traditional models such as two-dimensional (2D) cell cultures and animal models. However, these methods have significant limitations. 2D cultures fail to replicate ...
The life science group Sartorius launches the new Incucyte® CX3 Live-Cell Analysis System, delivering the most advanced capabilities for 3D cell culture applications. Expanding the Incucyte® ...
(MENAFN- EIN Presswire) EINPresswire/ -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire the DOPPL SA, a ...
InSphero acquires DOPPL SA and Sun Bioscience’s Gri3D® platform, expanding its unified 3D spheroid–organoid ecosystem for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback